XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 19,854 $ 22,063
Selling, general and administrative 17,435 7,241
Total operating expenses 37,289 29,304
Loss from operations (37,289) (29,304)
Other (expense) income, net:    
Interest income 1,066 835
Interest expense (1,874) (1,109)
Other income, net 105 123
Total other (expense) income, net (14,458) 5,288
Loss before provision for income taxes (51,747) (24,016)
Provision for income taxes 19 4
Net loss $ (51,766) $ (24,020)
Net loss per share attributable to common stockholders—basic $ (0.26) $ (0.16)
Net loss per share attributable to common stockholders—diluted $ (0.26) $ (0.16)
Weighted average shares of common stock outstanding—diluted 199,991,597 145,967,476
Weighted average shares of common stock outstanding—basic 199,991,597 145,967,476
Supplemental Income Statement Elements [Abstract]    
Change in unrealized loss related to available-for-sale debt securities $ (36) $ 0
Comprehensive loss (51,802) (24,020)
Warrant Liability    
Other (expense) income, net:    
Derivative, gain (loss) on derivative, net $ (13,755) $ 5,439